Jiangsu Hualv Biological Technology Co.Ltd. (300970) — Free Cash Flow Generation Index
Jiangsu Hualv Biological Technology Co.Ltd. (300970) has a Free Cash Flow Generation Index of 0.64x as of December 2025. Free cash flow of CN¥222.19 Million represents 1% of operating cash flow (CN¥345.31 Million). Explore Jiangsu Hualv Biological Technology Co.L capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Jiangsu Hualv Biological Technology Co.Ltd. Free Cash Flow Generation Index (2019–2025)
Historical FCF Generation Index trend for Jiangsu Hualv Biological Technology Co.Ltd. across 7 annual periods. For the full cash flow conversion analysis, see 300970 operating cash flow.
Annual Free Cash Flow Generation for Jiangsu Hualv Biological Technology Co.Ltd. (2019–2025)
Year-by-year Free Cash Flow Generation Index for Jiangsu Hualv Biological Technology Co.Ltd.. Check total reinvestment intensity of Jiangsu Hualv Biological Technology Co.L to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.64x | CN¥222.19 Million | CN¥345.31 Million | CN¥123.12 Million | ▲ +168.0% |
| 2024 | -0.95x | CN¥-130.42 Million | CN¥137.80 Million | CN¥268.22 Million | ▼ -174.4% |
| 2023 | -0.34x | CN¥-57.48 Million | CN¥166.67 Million | CN¥224.15 Million | ▲ +72.8% |
| 2022 | -1.27x | CN¥-228.07 Million | CN¥179.84 Million | CN¥407.91 Million | ▲ +12.9% |
| 2021 | -1.46x | CN¥-121.01 Million | CN¥83.08 Million | CN¥204.09 Million | ▼ -3667.9% |
| 2020 | 0.04x | CN¥8.13 Million | CN¥199.09 Million | CN¥190.96 Million | ▼ -92.4% |
| 2019 | 0.54x | CN¥115.42 Million | CN¥213.96 Million | CN¥98.54 Million | — |